Literature DB >> 7673515

Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme.

Y Nakamura1, N Yamamoto, K Sakai, T Takano.   

Abstract

This study reports the antihypertensive effect of orally administered doses of either Calpis sour milk or peptides (Val-Pro-Pro and Ile-Pro-Pro), which are inhibitors to angiotensin I-converting enzyme, isolated from the sour milk using strain SHR spontaneously hypertensive rats. Single oral administration of the sour milk (5 ml/kg of BW), corresponding inhibitory units of the peptides Val-Pro-Pro (.6 mg/kg of BW), or Ile-Pro-Pro (.3 mg/kg of BW) significantly decreased the systolic blood pressure from 6 to 8 h after administration. Blood pressure returned to the initial level at 24 h after administration. Antihypertensive activity of these two tripeptides was dose-dependent up to 5 mg/kg of BW. Conversely, the sour milk (25 ml/kg of BW) and mixed tripeptides (10 mg each of Val-Pro-Pro and Ile-Pro-Pro/kg of BW) did not change the systolic blood pressure of the normotensive strain WKY Wistar-Kyoto rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673515     DOI: 10.3168/jds.S0022-0302(95)76745-5

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  53 in total

Review 1.  Bioactive peptides of animal origin: a review.

Authors:  Z F Bhat; Sunil Kumar; Hina Fayaz Bhat
Journal:  J Food Sci Technol       Date:  2015-01-21       Impact factor: 2.701

Review 2.  Kefir: a multifaceted fermented dairy product.

Authors:  Barbara Nielsen; G Candan Gürakan; Gülhan Unlü
Journal:  Probiotics Antimicrob Proteins       Date:  2014-12       Impact factor: 4.609

3.  Dairy Food Intake and All-Cause, Cardiovascular Disease, and Cancer Mortality: The Golestan Cohort Study.

Authors:  Maryam S Farvid; Akbar F Malekshah; Akram Pourshams; Hossein Poustchi; Sadaf G Sepanlou; Maryam Sharafkhah; Masoud Khoshnia; Mojtaba Farvid; Christian C Abnet; Farin Kamangar; Sanford M Dawsey; Paul Brennan; Paul D Pharoah; Paolo Boffetta; Walter C Willett; Reza Malekzadeh
Journal:  Am J Epidemiol       Date:  2017-04-15       Impact factor: 4.897

Review 4.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

Review 5.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

6.  Antihypertensive peptides from whey proteins fermented by lactic acid bacteria.

Authors:  Eric Banan-Mwine Daliri; Byong H Lee; Byun-Jae Park; Se-Hun Kim; Deog-Hwan Oh
Journal:  Food Sci Biotechnol       Date:  2018-07-06       Impact factor: 2.391

Review 7.  Novel perspectives on fermented milks and cardiometabolic health with a focus on type 2 diabetes.

Authors:  Melissa Anne Fernandez; André Marette
Journal:  Nutr Rev       Date:  2018-12-01       Impact factor: 7.110

8.  Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes.

Authors:  Tiina Jauhiainen; Taru Pilvi; Zhong Jian Cheng; Hannu Kautiainen; Dominik N Müller; Heikki Vapaatalo; Riitta Korpela; Eero Mervaala
Journal:  J Nutr Metab       Date:  2009-11-30

9.  Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.

Authors:  M Hayes; C Stanton; H Slattery; O O'Sullivan; C Hill; G F Fitzgerald; R P Ross
Journal:  Appl Environ Microbiol       Date:  2007-05-04       Impact factor: 4.792

10.  Synthesis of gamma-aminobutyric acid by lactic acid bacteria isolated from a variety of Italian cheeses.

Authors:  S Siragusa; M De Angelis; R Di Cagno; C G Rizzello; R Coda; M Gobbetti
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.